KCT0009207Active, not recruitingUnknown
Pilot study for the association between fibroblast and clinicopathologic features in pancreatic cancer and cholangiocarcinoma
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Active, not recruiting
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20(Year) to o Limit (—)
- Sex
- All
Inclusion Criteria
- •Adults over 20 years old
- •- Patients suspected of having pancreatic cancer or biliary tract cancer on imaging tests including CT and PET/CT and confirmed to have cancer on biopsy
- •- Patients in whom cancer was not confirmed on biopsy due to difficulty in histological examination before surgery, but surgical treatment was planned due to strong suspicion of cancer based on clinical picture and imaging examination
- •- Patients who can provide written consent and comply with the research requirements before starting to participate in the study.
- •- Patients who gave written consent to establish a Bio Repository for liver, biliary tract, and pancreatic tumor research (H-0901-010-267)
Exclusion Criteria
- •- Patients who are pregnant or lactating
- •- Patients with a history of clinically significant uncontrolled seizures, central nervous system disease, or mental illness that, in the opinion of the investigator, may interfere with or interfere with the subject's ability to understand the consent form.
- •- Subjects who develop uncontrolled severe infection or other uncontrolled serious comorbidities
- •- Patients who have undergone other major surgery within 4 weeks prior to the study or who have not fully recovered from the effects of major surgery.
Investigators
Similar Trials
Recruiting
Unknown
Pilot study of fibroblast activation factor expression in recurrent/progressive pancreatic cancer and mesothelioma using [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) -46 PET imaging.pancreatic cancerACTRN12623001078640Sir Charles Gairdner and Osborne Park Health Care Group30
Recruiting
Not Applicable
Study to determine levels of Fibroblast Growth Factor 23 and other associated markers of bone turnover in men with various iron store states of iron overload, iron deficiency and normal iron stores.ACTRN12613000594729Associate Professor Emily Hibbert140
Completed
Phase 3
A Non-Inferiority Study Evaluating Fibroblast Growth Factor-2 (KCB-1D) to Enamel Matrix Derivative (Emdogain(R)Gel) for Periodontal Tissue Regeneration.patients with periodontitis who require surgical intervention (flap surgery)JPRN-UMIN000008231KAKEN PHARMACEUTICAL CO., LTD.240
Completed
Not Applicable
The efficacy of fibroblast growth factor for the treatment of chronic vocal fold scarringSymptoms, signs and abnormal clinical and laboratory findings, NECKCT0001855Soon Chun Hyang University Hospital Bucheon17
Completed
Not Applicable
Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal AdenocarcinomaRectum AdenocarcinomaNCT02849158Institut Curie14